Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
16 Apr 24
DEF 14A
Definitive proxy
16 Apr 24
8-K
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
28 Mar 24
8-K
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023
26 Mar 24
10-K
2023 FY
Annual report
25 Mar 24
8-K
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive
19 Mar 24
424B5
Prospectus supplement for primary offering
11 Mar 24
8-K
Entry into a Material Definitive Agreement
11 Mar 24
8-K
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds
29 Feb 24
8-K
Enveric Biosciences Unveils Library of Preclinical Compounds Across Multiple Distinct Molecule Classes Targeting Mental Health Disorders
21 Feb 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9 Feb 24
424B3
Prospectus supplement
24 Jan 24
EFFECT
Notice of effectiveness
23 Jan 24
CORRESP
Correspondence with SEC
19 Jan 24
UPLOAD
Letter from SEC
16 Jan 24
S-3
Shelf registration
11 Jan 24
8-K
Cost Associated with Exit or Disposal Activities
8 Jan 24
8-K
Enveric Biosciences Updates Key Data Underpinning Selection of EB-003 as Lead Drug Candidate from EVM301 Series
3 Jan 24
8-K
Entry into a Material Definitive Agreement
29 Dec 23
8-K
Enveric to initiate preclinical development of EB-003 in 2024 in preparation for IND submission
28 Dec 23
8-K
Enveric Biosciences Reports Year End Progress for Preclinical Development of Lead Prodrug Candidate EB-373
27 Dec 23
424B4
Prospectus supplement with pricing info
6 Dec 23
EFFECT
Notice of effectiveness
6 Dec 23
8-K
Three novel neuroplastic compounds identified with plans to advance one into expedited preclinical development in 2024
5 Dec 23
CORRESP
Correspondence with SEC
4 Dec 23
S-1/A
IPO registration (amended)
1 Dec 23
8-K
Enveric Biosciences Receives Notice of Allowance from USPTO for Development of Glycosylated Psilocybin Derivatives
29 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
22 Nov 23
UPLOAD
Letter from SEC
16 Nov 23
8-K
Enveric Biosciences Reports Third Quarter 2023 Corporate and Financial Results
13 Nov 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
S-1
IPO registration
7 Nov 23
8-K
Entry into a Material Definitive Agreement
6 Nov 23
8-K
Departure of Directors or Certain Officers
2 Nov 23
8-K
Regulation FD Disclosure
31 Oct 23
8-K
Enveric Biosciences to Present at the Centurion One 5th Global Summit
20 Oct 23
8-K
Key preclinical milestone designed to establish safety profile and maximum tolerated dose for anticipated clinical trial of EB-373
18 Oct 23
8-K
Enveric Biosciences Announces Two Poster Presentations at the 6th Neuropsychiatric Drug Development Summit
11 Oct 23
8-K
Enveric Biosciences Announces its Psybrary™ Portfolio Now Totals Over 1000 Psychedelic-Inspired Therapeutic Candidates
3 Oct 23
8-K
Regulation FD Disclosure
27 Sep 23
Latest ownership filings
4
Joseph Edward Tucker
26 Feb 24
4
Peter J. Facchini
26 Feb 24
4
Kevin Michael Coveney
26 Feb 24
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 24
SC 13G/A
INTRACOASTAL CAPITAL, LLC
6 Feb 24
SC 13G/A
Hudson Bay Capital Management LP
5 Feb 24
4
FRANK PASQUALONE
19 Sep 23
4
Kevin Michael Coveney
14 Mar 23
3
Kevin Michael Coveney
14 Mar 23
SC 13G
AdvisorShares Trust
14 Feb 23
SC 13G/A
INTRACOASTAL CAPITAL, LLC
8 Feb 23
SC 13G
Hudson Bay Capital Management LP
7 Feb 23
SC 13G/A
ALPHA CAPITAL ANSTALT
6 Feb 23
4
Peter J. Facchini
27 Jan 23
4
Jillian Marie Hagel
27 Jan 23
4
Avani Kanubaddi
27 Jan 23
4
Joseph Edward Tucker
27 Jan 23
4
Jillian Marie Hagel
25 Jan 23
4
Peter J. Facchini
25 Jan 23
4
Joseph Edward Tucker
25 Jan 23
3
Robert IV Dickey
23 Sep 22
SC 13G
INTRACOASTAL CAPITAL, LLC
1 Aug 22
3
FRANK PASQUALONE
22 Jul 22
3
BEVIN O'NEIL
5 Jul 22
3
MICHAEL D WEBB
22 Jun 22
4
Carter Julian Ward
25 Jan 22
4
Avani Kanubaddi
25 Jan 22
SC 13G/A
ALPHA CAPITAL ANSTALT
18 Jan 22
4
Jillian Marie Hagel
18 Oct 21
3
Jillian Marie Hagel
18 Oct 21
4
Peter J. Facchini
15 Oct 21
3
Peter J. Facchini
15 Oct 21
4/A
Joseph Edward Tucker
12 Oct 21
4
Joseph Edward Tucker
27 Sep 21
4
Bradley George Thompson
27 Sep 21
3
Joseph Edward Tucker
27 Sep 21
3
Bradley George Thompson
27 Sep 21
3
Carter Julian Ward
27 May 21
4
DOUGLAS LIND
2 Apr 21
3
DOUGLAS LIND
2 Apr 21